In fact, out of 107 prostate human adenocarcinomas analyzed, 61 % of prostate tumors had high caspase 6 activity, suggesting apoptotic deregulation may occur in early stages of prostate cancer [18]. The gene discussed is CASP6; the disease is prostate cancer.